Spelling suggestions: "subject:"ekc"" "subject:"ckc""
81 |
Role of ROK and PKC in Permeabilized Rabbit Femoral ArteryClelland, Lyndsay Jacquelyn 01 January 2007 (has links)
Discoveries made with KCl-induced contractions have elucidated the more complex reactions involved in GPCRs signaling; once the mechanisms of smooth muscle Ca2+ sensitization and desensitization are fully understood, then the development of advanced treatments for vascular disorders such as hypertension, cerebral and coronary vasospasm, and vascular hyporeactivity following hemorrhagic shock may be possible. Studies have shown that KCl-induced contractions induce Ca2+-sensitization. Therefore, we tested the hypothesis that KCl induced Ca2+-sensitization is due to ROK activation by the increase in [Ca2+]i. To test this hypothesis, rabbit femoral arteries were permeabilized with 20µg/ml α-toxin and 1% Triton X-100 and subjected to different calcium concentrations in the presence or absence of various ROK inhibitors. For a comparison we also used various PKC and MLCK inhibitors and repeated these experiments in intact tissues. We found that either [Ca2+]i alone does not directly activate ROK or the permeabilization technique itself disrupts the normal ROK signaling system. Secondary findings revealed that α-toxin activates PKC pathways; in both chemically permeabilized preparations proteases also appear to be activated and MLCK is the primary kinase responsible for contraction.
|
82 |
Enzymatic Regulation of Opioid Antinociception and ToleranceHull, Lynn 12 July 2009 (has links)
ENZYMATIC REGULATION OF OPIOID ANTINOCICEPTION AND TOLERANCE By Lynn C. Hull, Ph.D. A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy at Virginia Commonwealth University. Virginia Commonwealth University, 2009 Director: William L. Dewey, Ph.D. Department of Pharmacology and Toxicology The involvement of kinases in opioid actions has long been established. The acute actions of opioids, through the Gi/Go G-proteins, cause the inhibition of adenylyl cyclase and therefore a decrease in protein kinase A (PKA) activation. Additionally, acute opioid administration may cause the G-protein to activate the phospholipase C (PLC)-mediated cascade leading to the activation of protein kinase C (PKC). The phosphorylation of the MOR which can lead to both desensitization by uncoupling of the G-protein coupled receptors (GPCRs) from the G-proteins and to internalization by recruitment of β-arrestins has long been identified as a key process in tolerance. Phosphorylation by PKA and PKC leads primarily to uncoupling of the receptor from the G-proteins. Phosphorylation of the receptor by G-protein coupled receptor kinase (GRK) leads to the recruitment of β-arrestins and internalization of the receptor. Many in vitro studies have come to the conclusion that GRK induced internalization plays a more central role in the tolerance to high efficacy opioids and a lesser role in low- and moderate-efficacy opioid tolerance. In fact it has been hypothesized that morphine, a moderate-efficacy opioid, causes no internalization at all, while the desensitization of the receptor via phosphorylation by PKA and PKC plays a more central role in low- and moderate-efficacy opioid tolerance. We sought to test these in vitro findings in an in vivo model of opioid tolerance. Animals were made tolerant to one of a number of opioids of varying efficacy (low-efficacy meperidine, moderate-efficacy morphine and fentanyl, and high-efficacy [D-Ala2, N-MePhe4, Gly-ol]-enkephalin (DAMGO)) over an 8 hour period and then were administered one of the kinases’ inhibitors. Tolerance reversal was determined by challenging these mice with the same opioids to which they were tolerant. Calcium is known to play an important role in the acute antinociceptive actions of opioids as well as in opioid tolerance. Therefore it is important to determine how opioids are affecting the regulation of intracellular calcium. Our laboratory has previously shown that Calcium Induced Calcium Release (CICR), the ryanodine receptor and intracellular microsomal Ca2+ pools all play a role in opioids’ actions. It is also well known that mammalian ADP-ribosyl cyclase, CD38’s, product cADPR acts on the ryanodine receptor to cause Ca2+ release into the intracellular space. We chemically and genetically altered CD38 and then tested the acute effect of morphine as well as what effect these treatments had on morphine tolerance to determine what role if any, that CD38 may play in the acute actions of morphine antinociception as well as in morphine tolerance. Together, studies focusing on the role of an ADP-ribosyl cyclase, CD38, and 3 separate kinases, PKA, PKC and GRK, in opioids’ actions were performed in order to better understand the roles of these enzymes’ pathways in the actions of opioid-induced antinociception and subsequent development of tolerance. It is hoped that the results herein add useful knowledge to the general understanding of this drug class, and will one day be of use in the development of future analgesics and in the clinical treatment of pain and reduction in tolerance.
|
83 |
Investigation du rôle des molécules de signalisation cellulaire dans la lipidation de l'apolipoprotéine A-IHaidar, Bassam January 2003 (has links)
Thèse numérisée par la Direction des bibliothèques de l'Université de Montréal.
|
84 |
Étude de la signalisation virale de l'induction du gène de l'IL-15 dans les cellules monocytaires THP-1Ennaciri, Jamila January 2006 (has links)
Thèse numérisée par la Direction des bibliothèques de l'Université de Montréal.
|
85 |
Signalisation cellulaire et formation de complexes protéiques lors de l'étirement des cardiomyocytes de rats nouveaux-nés / Cellular signaling and protein complexes formation during neonatal rat cardiomyocytes stretchDuquesnes, Nicolas 18 April 2008 (has links)
L'étirement est un stimulus hypertrophique qui active de nombreuses voies de signalisation similaires à celles mises en évidence lors de l'étude de l'hypertrophie cellulaire. L'objectif principal de mon travail de thèse était de caractériser les évènements moléculaires impliqués dans l'activation des MAPKinases (MAPK), ERK et JNK lors de l'étirement. Nous avons étudié ces protéines par 2 approches différentes. D'une part, nous nous sommes intéressés aux rôles de protéines potentiellement nécessaires à l'activation des MAPK. D'autre part, nous avons cherché à mettre en évidence des interconnexions moléculaires entre les différentes voies de signalisation activées par l'étirement cellulaire, en montrant notamment la formation de complexes protéiques nécessaires à l'activation des différents partenaires. Nous montrons ainsi que deux protéines à activité tyrosine kinase, l'Epidermal Growth Factor Receptor (EGFR) et la Proline-rich tyrosine kinase 2 (Pyk2), sont respectivement nécessaires à l'activation de ERK et de JNK lors de l'étirement. Ces cascades de transduction peuvent être dépendantes de la petite protéine G Ras. Bien que les voies des MAPK et de PI3K/Akt soient considérées comme indépendantes, nous montrons également que Akt participe à l'activation de ERK par l'étirement. Enfin, nous avons montré la formation d'un complexe Protein Kinase C (PKC)/Calcineurine nécessaire à l'activation et à la translocation de la PKC lors de l'étirement. Cette étude de différentes voies de signalisation et des interactions protéiques apporte une meilleure connaissance des mécanismes activés par l'étirement cellulaire et permet donc de mieux comprendre la signalisation impliquée dans l'hypertrophie ventriculaire / Cardiomyocyte stretch is a major determinant of ventricular hypertrophy. It stimulates numerous signalling pathways leading to the Mitogen Activated Protein kinases (MAPK) activation. The objective of this thesis was to evaluate the molecular events involved in MAPK ERK and JNK activations during stretch. We studied these pathways by 2 different approaches. We analysed the role of several pivotal proteins involved in ERK and JNK activations and next we evaluated the molecular interactions between different signalling pathways by protein complexes formation induced by stretch and necessary for protein activations. We show that 2 tyrosine Kinases, the Epidermal Growth Factor Receptor (EGFR) and the Proline-rich tyrosine kinase 2 (Pyk2) are necessary for ERK and JNK activations respectively during stretch with a possible involvement of the small G protein Ras. MAPK and PI3/Akt pathways are generally considered independent but we show that ERK activation is PI3K/Akt dependent during stretch. Thus, we demonstrate that 2 other pathways are associated since PKC and calcineurin form a complex necessary for PKC activation and translocation. This study of signalling pathways and protein interactions sheds a new light on intracellular pathways leading to MAPK activation and may have implications for the development of new drugs in the management of cardiac hypertrophy and failure
|
86 |
Pain sensitization by parathyroid hormone-related peptide via convergent phosphoregulation of TRPV1Mickle, Aaron David 01 December 2014 (has links)
The neurobiological mechanisms underlying chronic pain in bone-metastasized breast and prostate cancer are not well understood although it is hypothesized that factors released in the tumor microenvironment may modulate sensory nociceptive sensory nerve fibers innervating the bone increasing pain sensation. Advanced metastatic breast and prostate cancer cells secrete high levels of parathyroid hormone-related peptide (PTHrP), which plays a critical role in metastasis to bones and subsequent tumor growth. PTHrP can activate parathyroid hormone receptor 1 (PTH1R), which signaling can activate either protein kinase C (PKC) and/or protein kinase A (PKA) depending on the tissue type. Both of these kinases are well known to modulate the nociceptive ion channel transient receptor potential vanilloid member 1 (TRPV1) due to which PTHrP constitutes an intriguing candidate that could modulate nociceptors, for pain sensitization related to cancer. TRPV1 can be activated by temperatures greater than 43°C and moderately acidic pH, less than pH 6. However, PKC and PKA phosphorylation of TRPV1 can potentiation channel activity by reducing the temperature of activation to 37°C and proton activation to pH 6.8 resulting in a channel that is constitutively active at body temperature or in the mildly acidic tumor microenvironment. Additionally, Src kinase, which under certain circumstances can be activated by PKC, can increase trafficking of TRPV1 to the plasma membrane, and enhance TRPV1-mediated signaling. Therefore, I hypothesize that PTHrP can sensitize TRPV1 and lead to an increase in nociceptive signaling.
First I show that intraplantar PTHrP injection causes a TRPV1-dependent increase in thermal and mechanical hypersensitivity in mice. PTHrP treatment of cultured mouse dorsal root ganglion (DRG) neurons enhances TRPV1 activation and increases action potential firing, which was dependent on PKC activation. Furthermore, co-injection of PKC inhibitor attenuated PTHrP-induced thermal hypersensitivity.
I also observed that PTHrP activated Src which led to an increase in the number of TRPV1-responsive neurons and an increase in TRPV1 protein level in the plasma membrane. While investigating the role of PTHrP-induced Src phosphorylation of TRPV1 I made a startling observation. Inhibition of Src phosphorylation of TRPV1 completely abolished PKC-induced potentiation of TRPV1. I found that Src phosphorylation of TRPV1 regulated PKC-induced potentiation of channel activity elicited by bradykinin, nerve growth factor and PMA. However, it did not regulate PKA induced potentiation of TRPV1 channel activity.
In summary, my results suggest that PTHrP in the tumor microenvironment could induce constitutive pathological sensitization of adjacent nociceptive sensory fibers via upregulation of TRPV1 function, trafficking and expression. These actions are dependent on Src and PKC phosphorylation of TRPV1. Additionally, I found that Src regulates PKC-induced phosphorylation of TRPV1 by PTHrP as well as other inflammatory mediators, suggesting a crucial role for Src in PKC-induced sensitization of TRPV1.
|
87 |
Développement d'inhibiteurs d'entrée du virus VIH-1Gaston, Fabrice 15 December 2008 (has links) (PDF)
La première étape du cycle viral du virus de l'immunodéficience humaine se déroule grâce à l'interaction entre les glycoprotéines d'enveloppe gp120/gp41 et les récepteurs CD4 et CCR5/CXCR4. Les différentes fonctions activées par cette étape, incluant l'attachement, la pénétration et la signalisation cellulaire représentent des cibles potentielles pour le développement d'antirétroviraux. Dans ce travail, nous avons développé des approches permettant d'agir sur chacune de ces étapes à l'aide de peptides synthétiques, d'anticorps anti-peptide et d'inhibiteurs des voies de signalisation. Dans la première approche, nous nous sommes intéressé au développement d'analogues peptidiques de la région HRII en évitant les limitations, incluant courte demi-vie et émergence d'isolats de résistance, rencontrées lors de l'utilisation du peptide T-20 (Fuzeon). Nous avons synthétisé un peptide de 34 acides aminés modélisant la région HRII en incluant des acides aminés non naturels de série D uniquement au niveau de certains sites sensibles à la protéolyse ou dans la totalité de la séquence.Les résultats obtenus montrent que les modifications ponctuelles permettent de : i) maintenir la structure en hélice a du peptide, ii) maintenir sa capacité à interagir avec la région HRI, iii) d'augmenter sa demie-vie et iv) de conserver son activité antivirale. Dans la deuxième approche, nous avons testé la capacité des peptides analogues de la région HRII de VIH-1 et de la boucle V3 de SIV à induire la production d'anticorps neutralisants. Cette étude nous a permis d'aboutir à deux conclusions principales : i) les anticorps anti-HRII peuvent interférer avec l'activité antivirale du peptide administré lors du traitement antiviral, ii) contrairement aux anticorps anti-V3 du VIH-1, les anticorps anti-V3 de SIV sont incapables de neutraliser le virus SIV suggérant des fonctions différentes pour cette région chez HIV-1 et SIV. Dans la troisième partie, nous avons montré que l'attachement du virus VIH sur son récepteur s'accompagne de l'activation de la voie PKC dont l'isoforme PKC-d. L'inhibition de cet isoforme bloque totalement la réplication virale. Ce blocage semble s'opérer en interférant avec les étapes post-entrée du virus en inhibant la formation des pseudopodes et des filaments d'actine, structure nécessaire pour l'étape de la transcription inverse.
|
88 |
Ras-MAPK signaling in differentiating SH-SY5Y human neuroblastoma cellsOlsson, Anna-Karin January 2000 (has links)
<p>Neuroblastoma is a malignant childhood cancer, originating from sympathetic neuroblasts of the peripheral nervous system. Neuroblastoma is a heterogenous group of tumours, while some are highly malignant others can spontaneosly mature into a more benign form or regress. Less than half of the patients survive and this statistics has improved only modestly over the past 20 years. </p><p>SH-SY5Y is a human neuroblastoma cell line established from a highly malignant tumour. The cells have retained a capacity to differentiate <i>in vitro</i> in response to low concentrations of the phorbolester 12-O-tetradecanoylphorbol-13-acetate (TPA) in the presence of serum or defined growth factors. Differentiated cells are characterised by neurite formation and upregulation of neuronal marker genes. SH-SY5Y are unresponsive to nerve growth factor (NGF), but when transfected to express the NGF-receptor TrkA, they differentiate in response to NGF. Protein kinase C (PKC) is pivotal for the differentiation response to take place.</p><p>We have investigated the role of signaling through the Ras-MAPK pathway in differentiating SH-SY5Y, with respect to neurite formation, expression of neuronal marker genes and growth control. Our results show that differentiation-promoting treatment induced a sustained activation and nuclear accumulation of the MAPK ERK in SH-SY5Y. The nuclear accumulation of ERK was PKC-dependent. However, nuclear accumulation of ERK was not sufficient for a differentiation response to take place in these cells, but ERK activity was needed for the characteristic upregulation of <i>NPY</i> and <i>GAP-43</i> induced by TPA. ERK activity did not induce neurite formation, neither was it necessary for TPA-induced neurite formation. Instead, stimulation of a pathway distinct from MEK/ERK, but downstream of Ras, was needed for morphological differentiation. We could also show that differentiated cells still entered S-phase and that there was no correlation between expression of the CKI p21<sub>cip1</sub> (an ERK target), BrdU-incorporation or neurite formation. </p>
|
89 |
Ras-MAPK signaling in differentiating SH-SY5Y human neuroblastoma cellsOlsson, Anna-Karin January 2000 (has links)
Neuroblastoma is a malignant childhood cancer, originating from sympathetic neuroblasts of the peripheral nervous system. Neuroblastoma is a heterogenous group of tumours, while some are highly malignant others can spontaneosly mature into a more benign form or regress. Less than half of the patients survive and this statistics has improved only modestly over the past 20 years. SH-SY5Y is a human neuroblastoma cell line established from a highly malignant tumour. The cells have retained a capacity to differentiate in vitro in response to low concentrations of the phorbolester 12-O-tetradecanoylphorbol-13-acetate (TPA) in the presence of serum or defined growth factors. Differentiated cells are characterised by neurite formation and upregulation of neuronal marker genes. SH-SY5Y are unresponsive to nerve growth factor (NGF), but when transfected to express the NGF-receptor TrkA, they differentiate in response to NGF. Protein kinase C (PKC) is pivotal for the differentiation response to take place. We have investigated the role of signaling through the Ras-MAPK pathway in differentiating SH-SY5Y, with respect to neurite formation, expression of neuronal marker genes and growth control. Our results show that differentiation-promoting treatment induced a sustained activation and nuclear accumulation of the MAPK ERK in SH-SY5Y. The nuclear accumulation of ERK was PKC-dependent. However, nuclear accumulation of ERK was not sufficient for a differentiation response to take place in these cells, but ERK activity was needed for the characteristic upregulation of NPY and GAP-43 induced by TPA. ERK activity did not induce neurite formation, neither was it necessary for TPA-induced neurite formation. Instead, stimulation of a pathway distinct from MEK/ERK, but downstream of Ras, was needed for morphological differentiation. We could also show that differentiated cells still entered S-phase and that there was no correlation between expression of the CKI p21cip1 (an ERK target), BrdU-incorporation or neurite formation.
|
90 |
Leishmania donovani Lipophosphoglycan : Modulation of Macrophage and Dendritic Cell FunctionTejle, Katarina January 2006 (has links)
Leishmania donovani is a blood-borne tropicial parasite, which infects humans through bites by Phlebotomus sandflies. The parasite survives and multiplies inside macrophages in inner organs, and causes the deadly disease visceral leishmaniasis (Kala-Azar). Macrophages and dendritic cells (DC) are professional antigen-presenting cells involved in the initiation of immune responses. Immature DC are present in all tissues where they internalise and process antigen, in response to which they migrate from tissue, into draining lymphoid organs, undergo maturation and present antigens to lymphocytes. Control measures for leishmaniasis include testing of new diagnostics and development of affordable and effective vaccines for humans. Lipophosphoglycan (LPG) is the major surface component of Leishmania donovani promastigotes. LPG comprises a membrane-anchoring lysophosphatidylinositol part and an extracellular chain of disaccharide phosphates. These repetitions are crucial for parasite survival inside macrophages following phagocytosis. LPG has several specific effects on the host cell including inhibition of protein kinase C (PKC) activity, and inhibition of phagosomal maturation, a process requiring depolymerization of periphagosomal F-actin. Confocal microscopy and image analysis were used to follow F-actin dynamics in single macrophages during phagocytosis of L. donovani promastigotes and LPG-coated particles. F-actin did not depolymerize, but instead progressively polymerized around phagosomes with LPG-containing prey. This correlated with reduced translocation of PKCα to the phagosome and blocked phagosomal maturation. LPG also inhibited cortical actin turnover, which could be the underlying cause of the reduced uptake of LPG-containing prey. Extracellular- and intracellular calcium was necessary for phagocytosis, periphagosomal F-actin breakdown and phagosomal maturation in macrophages interacting with unopsonized prey,and for the action of LPG. We also studied F-actin turnover in macrophages overexpressing dominant-negative (DN) PKCα. DN PKCα macrophages showed increased amounts of cortical F-actin, decreased phagocytic capacity, inhibition of periphagosomal F-actin breakdown and defective phagosomal maturation. When DN PKCα macrophages interacted with LPG-containing prey, phagocytosis was almost completely blocked. Moreover, we found that Leishmania promastigotes and particularly LPG inhibit DC maturation and detachment from distinct surfaces. Thus, LPG from Leishmania donovani could directly inhibit DC migration to lymphoid organs, antigen-presentation and development of immunity.
|
Page generated in 0.0548 seconds